Antibody-based profiling of cerebrospinal fluid within multiple sclerosis

Proteomics

Volumn 13, Issue 15, 2013, Pages 2256-2267

  Häggmark, Anna ^a   Byström, Sanna ^a   Ayoglu, Burcu ^a   Qundos, Ulrika ^a   Uhlén, Mathias ^a   Khademi, Mohsen ^b   Olsson, Tomas ^b   Schwenk, Jochen M ^a   Nilsson, Peter ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antibody microarrays; Biomarker discovery; Cerebrospinal fluid; Multiplexed proteomics technology; Protein arrays; Proteome profiling

Indexed keywords

ANTIBODY; BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN G; NEUROMODULIN;

ADOLESCENT; ADULT; AGED; ANTIBODY LABELING; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; FEMALE; HEAT TREATMENT; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN CONTENT; PROTEIN DETERMINATION; SENSITIVITY ANALYSIS;

EID: 84881230169     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200580     Document Type: Article

References (26)

1. Ayoglu, B., Haggmark, A., Neiman, M., Igel, U. et al., Systematic antibody and antigen-based proteomic profiling with microarrays. Expert Rev. Mol. Diagnost. 2011, 11, 219-234.
2. Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M. et al., How common are the "common" neurologic disorders? Neurology 2007, 68, 326-337.
3. Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F. et al., The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009, 132, 1175-1189.
4. Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M. et al., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69, 292-302.
5. Compston, A., Coles, A., Multiple sclerosis. Lancet 2008, 372, 1502-1517.
6. Dumont, D., Noben, J. P., Raus, J., Stinissen, P., Robben, J., Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004, 4, 2117-2124.
7. Hammack, B. N., Fung, K. Y., Hunsucker, S. W., Duncan, M. W. et al., Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult. Scler. 2004, 10, 245-260.
8. Komori, M., Matsuyama, Y., Nirasawa, T., Thiele, H. et al., Proteomic pattern analysis discriminates among multiple sclerosis-related disorders. Ann. Neurol. 2012, 71, 614-623.
9. Light, M., Minor, K. H., Dewitt, P., Jasper, K. H., Davies, S. J., Multiplex array proteomics detects increased MMP-8 in CSF after spinal cord injury. J. Neuroinflammation 2012, 9, 122.
10. Poetz, O., Henzler, T., Hartmann, M., Kazmaier, C. et al., Sequential multiplex analyte capturing for phosphoprotein profiling. Mol. Cell. Proteomics 2010, 9, 2474-2481.
11. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E. et al., Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 2010, 28, 1248-1250.
12. Schwenk, J. M., Gry, M., Rimini, R., Uhlen, M., Nilsson, P., Antibody suspension bead arrays within serum proteomics. J. Proteome Res. 2008, 7, 3168-3179.
13. Ihaka, R., Gentleman, R., R: A language for data analysis and graphics. J. Comput. Graph. Stat. 1996, 5, 299-314.
14. Dieterle, F., Ross, A., Schlotterbeck, G., Senn, H., Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal. Chem. 2006, 78, 4281-4290.
15. Kato, B. S., Nicholson, G., Neiman, M., Rantalainen, M. et al., Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model. Proteome Sci. 2011, 9, 73.
16. Hubert, M., Rousseeuw, P. J., Branden, K. V., ROBPCA: A new approach to robust principal component analysis. Technometrics 2005, 47, 64-79.
17. Schwenk, J. M., Igel, U., Neiman, M., Langen, H. et al., Toward next generation plasma profiling via heat-induced epitope retrieval and array-based assays. Mol. Cell. Proteomics 2010, 9, 2497-2507.
18. Regeniter, A., Kuhle, J., Mehling, M., Moller, H. et al., A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting. Clin. Neurol. Neurosurg. 2009, 111, 313-318.
19. Rosenberg, G. A., Neurological diseases in relation to the blood-brain barrier. J. Cereb. Blood. Flow. Metab. 2012, 32, 1139-1151.
20. Thouvenot, E., Urbach, S., Dantec, C., Poncet, J. et al., Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluid. J. Proteome Res. 2008, 7, 4409-4421.
21. Granger, J., Siddiqui, J., Copeland, S., Remick, D., Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 2005, 5, 4713-4718.
22. Landegren, U., Vanelid, J., Hammond, M., Nong, R. Y. et al., Opportunities for sensitive plasma proteome analysis. Anal. Chem. 2012, 84, 1824-1830.
23. Oestreicher, A. B., De Graan, P. N., Gispen, W. H., Verhaagen, J., Schrama, L. H., B-50, the growth associated protein-43: modulation of cell morphology and communication in the nervous system. Prog. Neurobiol. 1997, 53, 627-686.
24. Teunissen, C. E., Dijkstra, C. D., Jasperse, B., Barkhof, F. et al., Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis. Neuropathol. Appl. Neurobiol. 2006, 32, 318-331.
25. Licastro, F., Candore, G., Lio, D., Porcellini, E. et al., Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun. Ageing 2005, 2, 8.
26. Ottervald, J., Franzen, B., Nilsson, K., Andersson, L. I. et al., Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers. J. Proteomics 2010, 73, 1117-1132.